ARCOSA INC (ACA) Fundamental Analysis & Valuation

NYSE:ACA • US0396531008

Current stock price

102.52 USD
+0.35 (+0.34%)
Last:

This ACA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. ACA Profitability Analysis

1.1 Basic Checks

  • In the past year ACA was profitable.
  • ACA had a positive operating cash flow in the past year.
  • Of the past 5 years ACA 4 years were profitable.
  • Of the past 5 years ACA 4 years had a positive operating cash flow.
ACA Yearly Net Income VS EBIT VS OCF VS FCFACA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

1.2 Ratios

  • ACA has a Return On Assets (2.94%) which is in line with its industry peers.
  • ACA has a Return On Equity (5.75%) which is comparable to the rest of the industry.
  • The Return On Invested Capital of ACA (4.99%) is comparable to the rest of the industry.
  • The Average Return On Invested Capital over the past 3 years for ACA is significantly below the industry average of 17.30%.
  • The 3 year average ROIC (3.99%) for ACA is below the current ROIC(4.99%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.94%
ROE 5.75%
ROIC 4.99%
ROA(3y)4.56%
ROA(5y)3.97%
ROE(3y)7.3%
ROE(5y)6.21%
ROIC(3y)3.99%
ROIC(5y)4.04%
ACA Yearly ROA, ROE, ROICACA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

  • The Profit Margin of ACA (5.25%) is better than 62.50% of its industry peers.
  • In the last couple of years the Profit Margin of ACA has declined.
  • ACA's Operating Margin of 10.27% is fine compared to the rest of the industry. ACA outperforms 69.64% of its industry peers.
  • In the last couple of years the Operating Margin of ACA has declined.
  • Looking at the Gross Margin, with a value of 21.61%, ACA is in the better half of the industry, outperforming 67.86% of the companies in the same industry.
  • ACA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 10.27%
PM (TTM) 5.25%
GM 21.61%
OM growth 3Y11.96%
OM growth 5Y-2.91%
PM growth 3Y2.37%
PM growth 5Y-10.81%
GM growth 3Y3.69%
GM growth 5Y0.93%
ACA Yearly Profit, Operating, Gross MarginsACA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. ACA Health Analysis

2.1 Basic Checks

  • ACA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • There is no outstanding debt for ACA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ACA Yearly Shares OutstandingACA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
ACA Yearly Total Debt VS Total AssetsACA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

  • An Altman-Z score of 2.36 indicates that ACA is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • ACA has a Altman-Z score (2.36) which is comparable to the rest of the industry.
  • The Debt to FCF ratio of ACA is 5.03, which is a neutral value as it means it would take ACA, 5.03 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 5.03, ACA is in the better half of the industry, outperforming 62.50% of the companies in the same industry.
  • ACA has a Debt/Equity ratio of 0.61. This is a neutral value indicating ACA is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.61, ACA perfoms like the industry average, outperforming 53.57% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 5.03
Altman-Z 2.36
ROIC/WACC0.52
WACC9.67%
ACA Yearly LT Debt VS Equity VS FCFACA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.3 Liquidity

  • ACA has a Current Ratio of 2.02. This indicates that ACA is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 2.02, ACA belongs to the top of the industry, outperforming 89.29% of the companies in the same industry.
  • A Quick Ratio of 1.30 indicates that ACA should not have too much problems paying its short term obligations.
  • ACA has a better Quick ratio (1.30) than 64.29% of its industry peers.
Industry RankSector Rank
Current Ratio 2.02
Quick Ratio 1.3
ACA Yearly Current Assets VS Current LiabilitesACA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. ACA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 48.50% over the past year.
  • Measured over the past years, ACA shows a quite strong growth in Earnings Per Share. The EPS has been growing by 12.78% on average per year.
EPS 1Y (TTM)48.5%
EPS 3Y26.66%
EPS 5Y12.78%
EPS Q2Q%150%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%7.58%

3.2 Future

  • ACA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.17% yearly.
  • The Revenue is expected to grow by 5.28% on average over the next years.
EPS Next Y9.06%
EPS Next 2Y11.17%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.18%
Revenue Next 2Y5.28%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ACA Yearly Revenue VS EstimatesACA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
ACA Yearly EPS VS EstimatesACA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

4

4. ACA Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 22.94 indicates a rather expensive valuation of ACA.
  • Compared to the rest of the industry, the Price/Earnings ratio of ACA indicates a somewhat cheap valuation: ACA is cheaper than 78.57% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 25.73. ACA is around the same levels.
  • A Price/Forward Earnings ratio of 21.03 indicates a rather expensive valuation of ACA.
  • 76.79% of the companies in the same industry are more expensive than ACA, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 23.72. ACA is around the same levels.
Industry RankSector Rank
PE 22.94
Fwd PE 21.03
ACA Price Earnings VS Forward Price EarningsACA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ACA is valued cheaply inside the industry as 80.36% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, ACA is valued cheaply inside the industry as 83.93% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 15.98
EV/EBITDA 12.32
ACA Per share dataACA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ACA does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)2.53
PEG (5Y)1.79
EPS Next 2Y11.17%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. ACA Dividend Analysis

5.1 Amount

  • ACA has a yearly dividend return of 0.19%, which is pretty low.
  • Compared to an average industry Dividend Yield of 0.14, ACA pays a better dividend. On top of this ACA pays more dividend than 80.36% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.91, ACA's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.19%

5.2 History

  • The dividend of ACA decreases each year by -0.48%.
  • ACA has been paying a dividend for over 5 years, so it has already some track record.
  • As ACA did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)-0.48%
Div Incr Years0
Div Non Decr Years5
ACA Yearly Dividends per shareACA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.05 0.1 0.15

5.3 Sustainability

  • ACA pays out 6.66% of its income as dividend. This is a sustainable payout ratio.
DP6.66%
EPS Next 2Y11.17%
EPS Next 3YN/A
ACA Yearly Income VS Free CF VS DividendACA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
ACA Dividend Payout.ACA Dividend Payout, showing the Payout Ratio.ACA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ACA Fundamentals: All Metrics, Ratios and Statistics

ARCOSA INC

NYSE:ACA (3/20/2026, 2:25:01 PM)

102.52

+0.35 (+0.34%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)02-26
Earnings (Next)05-04
Inst Owners94.27%
Inst Owner Change-3.24%
Ins Owners1.85%
Ins Owner Change2.68%
Market Cap5.03B
Revenue(TTM)N/A
Net Income(TTM)148.60M
Analysts84.44
Price Target125.66 (22.57%)
Short Float %1.88%
Short Ratio3.15
Dividend
Industry RankSector Rank
Dividend Yield 0.19%
Yearly Dividend0.2
Dividend Growth(5Y)-0.48%
DP6.66%
Div Incr Years0
Div Non Decr Years5
Ex-Date04-15
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.63%
Min EPS beat(2)15.61%
Max EPS beat(2)17.65%
EPS beat(4)3
Avg EPS beat(4)38.79%
Min EPS beat(4)-40.32%
Max EPS beat(4)162.24%
EPS beat(8)7
Avg EPS beat(8)30.62%
EPS beat(12)11
Avg EPS beat(12)32.12%
EPS beat(16)15
Avg EPS beat(16)40.53%
Revenue beat(2)1
Avg Revenue beat(2)-1.27%
Min Revenue beat(2)-3.72%
Max Revenue beat(2)1.18%
Revenue beat(4)2
Avg Revenue beat(4)-1.29%
Min Revenue beat(4)-4.44%
Max Revenue beat(4)1.83%
Revenue beat(8)4
Avg Revenue beat(8)-0.83%
Revenue beat(12)7
Avg Revenue beat(12)0.53%
Revenue beat(16)11
Avg Revenue beat(16)1.99%
PT rev (1m)-0.48%
PT rev (3m)2.81%
EPS NQ rev (1m)-0.54%
EPS NQ rev (3m)-1.1%
EPS NY rev (1m)-0.12%
EPS NY rev (3m)0.17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.46%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)0.07%
Valuation
Industry RankSector Rank
PE 22.94
Fwd PE 21.03
P/S 1.77
P/FCF 15.98
P/OCF 10.71
P/B 1.94
P/tB 5.47
EV/EBITDA 12.32
EPS(TTM)4.47
EY4.36%
EPS(NY)4.88
Fwd EY4.76%
FCF(TTM)6.42
FCFY6.26%
OCF(TTM)9.57
OCFY9.33%
SpS57.77
BVpS52.71
TBVpS18.73
PEG (NY)2.53
PEG (5Y)1.79
Graham Number72.81
Profitability
Industry RankSector Rank
ROA 2.94%
ROE 5.75%
ROCE 6.5%
ROIC 4.99%
ROICexc 5.24%
ROICexgc 8.62%
OM 10.27%
PM (TTM) 5.25%
GM 21.61%
FCFM 11.11%
ROA(3y)4.56%
ROA(5y)3.97%
ROE(3y)7.3%
ROE(5y)6.21%
ROIC(3y)3.99%
ROIC(5y)4.04%
ROICexc(3y)4.17%
ROICexc(5y)4.21%
ROICexgc(3y)7.17%
ROICexgc(5y)7.33%
ROCE(3y)5.21%
ROCE(5y)5.27%
ROICexgc growth 3Y4.01%
ROICexgc growth 5Y-10.09%
ROICexc growth 3Y4.98%
ROICexc growth 5Y-11.63%
OM growth 3Y11.96%
OM growth 5Y-2.91%
PM growth 3Y2.37%
PM growth 5Y-10.81%
GM growth 3Y3.69%
GM growth 5Y0.93%
F-Score5
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 5.03
Debt/EBITDA 3.04
Cap/Depr 68.36%
Cap/Sales 5.46%
Interest Coverage 250
Cash Conversion 90.74%
Profit Quality 211.71%
Current Ratio 2.02
Quick Ratio 1.3
Altman-Z 2.36
F-Score5
WACC9.67%
ROIC/WACC0.52
Cap/Depr(3y)104.81%
Cap/Depr(5y)89.02%
Cap/Sales(3y)7.45%
Cap/Sales(5y)6.15%
Profit Quality(3y)128.08%
Profit Quality(5y)133.99%
High Growth Momentum
Growth
EPS 1Y (TTM)48.5%
EPS 3Y26.66%
EPS 5Y12.78%
EPS Q2Q%150%
EPS Next Y9.06%
EPS Next 2Y11.17%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%7.58%
Revenue Next Year5.18%
Revenue Next 2Y5.28%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y48.65%
EBIT growth 3Y20.99%
EBIT growth 5Y5.01%
EBIT Next Year135.6%
EBIT Next 3Y38.61%
EBIT Next 5YN/A
FCF growth 1Y5015.62%
FCF growth 3Y56.55%
FCF growth 5Y2.7%
OCF growth 1Y146.35%
OCF growth 3Y44.47%
OCF growth 5Y6.95%

ARCOSA INC / ACA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ARCOSA INC?

ChartMill assigns a fundamental rating of 5 / 10 to ACA.


Can you provide the valuation status for ARCOSA INC?

ChartMill assigns a valuation rating of 4 / 10 to ARCOSA INC (ACA). This can be considered as Fairly Valued.


How profitable is ARCOSA INC (ACA) stock?

ARCOSA INC (ACA) has a profitability rating of 5 / 10.


What is the valuation of ARCOSA INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ARCOSA INC (ACA) is 22.94 and the Price/Book (PB) ratio is 1.94.


How financially healthy is ARCOSA INC?

The financial health rating of ARCOSA INC (ACA) is 5 / 10.